These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3815360

  • 1. Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
    Bowdon BJ, Waud WR, Wheeler GP, Hain R, Dansby L, Temple C.
    Cancer Res; 1987 Mar 15; 47(6):1621-6. PubMed ID: 3815360
    [Abstract] [Full Text] [Related]

  • 2. Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines.
    Wheeler GP, Bowdon BJ, Temple C, Adamson DJ, Webster J.
    Cancer Res; 1983 Aug 15; 43(8):3567-75. PubMed ID: 6861128
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
    Yoshimatsu K, Yamaguchi A, Yoshino H, Koyanagi N, Kitoh K.
    Cancer Res; 1997 Aug 01; 57(15):3208-13. PubMed ID: 9242451
    [Abstract] [Full Text] [Related]

  • 4. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
    Temple C, Wheeler GP, Elliott RD, Rose JD, Comber RN, Montgomery JA.
    J Med Chem; 1983 Jan 01; 26(1):91-5. PubMed ID: 6827530
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928).
    Wheeler GP, Bowdon BJ, Werline JA, Adamson DJ, Temple CG.
    Cancer Res; 1982 Mar 01; 42(3):791-8. PubMed ID: 7059977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.
    Kelleher JK.
    Cancer Treat Rep; 1978 Oct 01; 62(10):1443-7. PubMed ID: 101303
    [Abstract] [Full Text] [Related]

  • 8. Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
    Chi DM, Shahrik LK, Ho HH, Hamel E.
    Cancer Res; 1989 Mar 15; 49(6):1344-8. PubMed ID: 2924291
    [Abstract] [Full Text] [Related]

  • 9. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM, Ladesich JB, Magill MJ, Chen Y, Hua DH, Perchellet JP.
    Anticancer Drugs; 1999 Jun 15; 10(5):489-504. PubMed ID: 10477169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binding of maytansine to tubulin: competition with other mitotic inhibitors.
    Lin CM, Hamel E, Wolpert-DeFilippes MK.
    Res Commun Chem Pathol Pharmacol; 1981 Mar 15; 31(3):443-51. PubMed ID: 7255878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K, Bishop J, Peck A, Brown J, Wilson L, Panda D.
    Biochemistry; 2004 Jun 01; 43(21):6645-55. PubMed ID: 15157098
    [Abstract] [Full Text] [Related]

  • 14. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A, Schmidt P, Baasner S, Böhm KJ, Müller K, Gerlach M, Günther EG, Unger E, Prinz H.
    J Med Chem; 2006 Dec 28; 49(26):7816-25. PubMed ID: 17181164
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.